-
EP3166596
European procedure
Extract from the Register of European Patents
EP About this file: EP3166596
| EP3166596 - PHARMACEUTICAL DOSAGE FORMS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 12.04.2019 Database last updated on 16.11.2024 | |
| Former | The patent has been granted Status updated on 04.05.2018 | ||
| Former | Grant of patent is intended Status updated on 17.04.2018 | ||
| Former | Request for examination was made Status updated on 27.03.2018 | ||
| Former | Grant of patent is intended Status updated on 16.11.2017 | ||
| Former | Request for examination was made Status updated on 18.04.2017 | ||
| Former | The international publication has been made Status updated on 16.12.2016 | Most recent event Tooltip | 26.06.2020 | Lapse of the patent in a contracting state New state(s): MK | published on 29.07.2020 [2020/31] | Applicant(s) | For all designated states Novartis AG Lichtstrasse 35 4056 Basel / CH | [2017/20] | Inventor(s) | 01 /
BEATO, Stefania c/o Novartis Pharma AG Postfach CH-4002 Basel / CH | 02 /
QUINTON, Peggy c/o Novartis Pharma AG Postfach CH-4002 Basel / CH | [2017/20] | Representative(s) | Petersen, Holger, et al Novartis Pharma AG Postfach 4002 Basel / CH | [2017/20] | Application number, filing date | 15738484.3 | 06.07.2015 | [2017/20] | WO2015IB55098 | Priority number, date | US201462021271P | 07.07.2014 Original published format: US 201462021271 P | [2017/20] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2016005880 | Date: | 14.01.2016 | Language: | EN | [2016/02] | Type: | A1 Application with search report | No.: | EP3166596 | Date: | 17.05.2017 | Language: | EN | The application published by WIPO in one of the EPO official languages on 14.01.2016 takes the place of the publication of the European patent application. | [2017/20] | Type: | B1 Patent specification | No.: | EP3166596 | Date: | 06.06.2018 | Language: | EN | [2018/23] | Search report(s) | International search report - published on: | EP | 14.01.2016 | Classification | IPC: | A61K9/20, A61K31/45 | [2017/20] | CPC: |
A61K9/2036 (EP,EA,IL,KR,US);
A61K9/2054 (EP,CN,EA,IL,KR,US);
A61K9/0053 (CN,EA,IL);
A61K31/4188 (CN,EA,IL,US);
A61K31/4184 (EP,EA,IL,US);
A61K31/45 (EA,IL,KR);
A61K9/20 (IL);
A61K9/2009 (EA,IL,US);
A61K9/2095 (EA,IL,US);
A61K9/2806 (CN,EA,IL);
A61K9/2813 (EA,IL,US);
A61K9/2826 (EA,IL,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/20] | Extension states | BA | 07.02.2017 | ME | 07.02.2017 | Validation states | MA | Not yet paid | Title | German: | DOSIERFORMEN FÜR ARZNEIMITTEL | [2017/20] | English: | PHARMACEUTICAL DOSAGE FORMS | [2017/20] | French: | FORMES PHARMACEUTIQUES | [2017/20] | Entry into regional phase | 07.02.2017 | National basic fee paid | 07.02.2017 | Designation fee(s) paid | 07.02.2017 | Examination fee paid | Examination procedure | 15.12.2016 | Date on which the examining division has become responsible | 07.02.2017 | Examination requested [2017/20] | 10.08.2017 | Amendment by applicant (claims and/or description) | 17.11.2017 | Communication of intention to grant the patent | 15.03.2018 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 15.03.2018 | Fee for grant paid | 15.03.2018 | Fee for publishing/printing paid | 16.04.2018 | Information about intention to grant a patent | 16.04.2018 | Receipt of the translation of the claim(s) | Divisional application(s) | EP18176177.6 / EP3412278 | Opposition(s) | 07.03.2019 | No opposition filed within time limit [2019/20] | Fees paid | Renewal fee | 12.07.2017 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AL | 06.06.2018 | MC | 06.06.2018 | MK | 06.06.2018 | RS | 06.06.2018 | SM | 06.06.2018 | [2020/31] |
| Former [2019/51] | AL | 06.06.2018 | |
| MC | 06.06.2018 | ||
| RS | 06.06.2018 | ||
| SM | 06.06.2018 | ||
| Former [2019/15] | MC | 06.06.2018 | |
| RS | 06.06.2018 | ||
| SM | 06.06.2018 | ||
| Former [2019/12] | RS | 06.06.2018 | |
| SM | 06.06.2018 | ||
| Former [2018/51] | RS | 06.06.2018 | Cited in | International search | [AD]WO2011088188 (NOVARTIS AG [CH], et al); | [A]WO2013153129 (NOVARTIS AG [CH], et al); | [XP]EP2815749 (IP GES FÜR MAN MBH [DE]) | by applicant | WO2007024945 | WO2011088188 | WO2013109514 |